Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
ANI Pharmaceuticals to Acquire Alimera Sciences in $381M Deal
ANI Pharmaceutical has signed a definitive agreement to acquire Alimera at approximately $381 million. The agreement has been approved by both companies’ Boards of Directors and is anticipated to close in the late third quarter of 2024. Alimera Sciences, a…
4DMT Receives FDA Clearance of IND for GA Treatment
4D Molecular Therapeutics (4DMT) announced the FDA clearance of its investigational new drug application (IND) for 4D-175, an R100 vector-based intravitreal genetic medicine intended for treating geographic atrophy (GA) in patients. Phase 1 GAZE Clinical Trial Details The phase 1…
Ikerian Receives EU-MDR Certificate for Four Medical Devices
Ikerian has received European Union Medical Device Regulation (EU-MDR) certificate for its RetinAI Discovery digital data platform and AI-based models. These products have been classified as Class IIa medical devices, affirming their adherence to stringent regulatory standards for healthcare technology.…
VSY Biotechnology’s SVT Granted Patent in China
VSY Biotechnology registered a patent with the People’s Republic of China for the ‘Sinusoidal Vision Technology’ used in AcrivaUD Trinova Pro C Pupil Adaptive®, the world’s first and only sinusoidal trifocal intraocular lens. As a result of evaluations, office actions,…
What Is Staphyloma? | OBN
Staphyloma is a bulging or protrusion of the eye’s inner layers through a thinned area of the outer layers. It is typically caused by a structural weakness in the eye, and it can lead to vision problems if left untreated.…
The 40th Congress of the ESCRS | Milan 16
The 40th Congress of the ESCRS is taking place from 16-20 September 2022, at the Milano Convention Centre in Milan, Italy. The congress, which will host around 1,000 registered participants, will also be streamed via the virtual conferencing platform now…
Novartis’ AMD Drug Linked to Rare Retinal Side Effects
Two recent studies have found that a drug called brolucizumab, which was approved in 2019 and developed by Swiss pharmaceutical company Novartis AG to treat wet age-related macular degeneration (AMD), can cause rare retinal side effects due to its interaction…
Use of Telemedicine in Ophthalmology
The medical industry is undergoing radical change as we enter the digital age. One such change is the advent of telemedicine – a powerful tool enabling healthcare providers to connect with patients remotely. Ophthalmology, the branch of medicine dedicated to…
What is Ophthalmology? | OBN
The word itself originates from Greek words phthalmos, “eye” and -logia, “study” and Ophthalmology means “the study of eyes”. Ophthalmology is the branch in medicine that concerns the medical conditions and health of the eyes. The discipline covers all animal…
DORC Receives FDA Clearance for Eva Nexus System
DORC International has announced 510(k) market clearance and the launch of the Eva Nexus. According to DORC, the Eva Nexus features multiple innovations to improve performance, efficiency, and stability for retina surgeons, including Smart IOP for anterior and posterior chamber stability; DORC’s trocar cannula system with HI-FLOW infusion…